| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | alpha-amylase activity | 4.11e-14 | 5 | 44 | 5 | GO:0004556 | |
| GeneOntologyMolecularFunction | amylase activity | 2.46e-13 | 6 | 44 | 5 | GO:0016160 | |
| GeneOntologyMolecularFunction | chloride ion binding | 1.76e-10 | 16 | 44 | 5 | GO:0031404 | |
| GeneOntologyMolecularFunction | hydrolase activity, hydrolyzing O-glycosyl compounds | 9.79e-08 | 103 | 44 | 6 | GO:0004553 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on glycosyl bonds | 7.14e-07 | 144 | 44 | 6 | GO:0016798 | |
| GeneOntologyMolecularFunction | calcium ion binding | 3.05e-05 | 749 | 44 | 9 | GO:0005509 | |
| GeneOntologyMolecularFunction | NAD transmembrane transporter activity | 4.73e-05 | 5 | 44 | 2 | GO:0051724 | |
| GeneOntologyMolecularFunction | adenine nucleotide transmembrane transporter activity | 1.49e-03 | 26 | 44 | 2 | GO:0000295 | |
| GeneOntologyMolecularFunction | purine nucleotide transmembrane transporter activity | 1.86e-03 | 29 | 44 | 2 | GO:0015216 | |
| GeneOntologyMolecularFunction | ATPase activator activity | 2.26e-03 | 32 | 44 | 2 | GO:0001671 | |
| GeneOntologyMolecularFunction | nucleotide transmembrane transporter activity | 2.40e-03 | 33 | 44 | 2 | GO:0015215 | |
| GeneOntologyBiologicalProcess | mitochondrial NAD transmembrane transport | 4.45e-06 | 2 | 44 | 2 | GO:1990549 | |
| GeneOntologyBiologicalProcess | regulatory ncRNA processing | 1.86e-05 | 74 | 44 | 4 | GO:0070918 | |
| GeneOntologyBiologicalProcess | NAD transmembrane transport | 4.43e-05 | 5 | 44 | 2 | GO:0035352 | |
| GeneOntologyBiologicalProcess | NAD transport | 6.64e-05 | 6 | 44 | 2 | GO:0043132 | |
| GeneOntologyCellularComponent | extracellular matrix | 4.67e-04 | 656 | 45 | 7 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 4.75e-04 | 658 | 45 | 7 | GO:0030312 | |
| MousePheno | absent P wave | 2.15e-05 | 4 | 27 | 2 | MP:0010510 | |
| MousePheno | urinary incontinence | 9.99e-05 | 8 | 27 | 2 | MP:0003280 | |
| Domain | Aamy_C | 2.00e-11 | 4 | 41 | 4 | SM00632 | |
| Domain | Alpha_amylase | 2.00e-11 | 4 | 41 | 4 | IPR006046 | |
| Domain | Alpha-amylase_C | 9.97e-11 | 5 | 41 | 4 | PF02806 | |
| Domain | A-amylase/branching_C | 9.97e-11 | 5 | 41 | 4 | IPR006048 | |
| Domain | Aamy | 6.96e-10 | 7 | 41 | 4 | SM00642 | |
| Domain | Glyco_hydro_13_cat_dom | 6.96e-10 | 7 | 41 | 4 | IPR006047 | |
| Domain | Alpha-amylase | 6.96e-10 | 7 | 41 | 4 | PF00128 | |
| Domain | A-amylase_C | 9.82e-09 | 3 | 41 | 3 | IPR031319 | |
| Domain | Glyco_hydro_catalytic_dom | 1.88e-08 | 38 | 41 | 5 | IPR013781 | |
| Domain | Glyco_hydro_b | 2.68e-08 | 15 | 41 | 4 | IPR013780 | |
| Domain | Glycoside_hydrolase_SF | 1.05e-07 | 53 | 41 | 5 | IPR017853 | |
| Domain | Glyco_hydro_13 | 1.95e-07 | 6 | 41 | 3 | IPR015902 | |
| Domain | - | 9.96e-07 | 35 | 41 | 4 | 3.20.20.80 | |
| Domain | - | 3.51e-06 | 14 | 41 | 3 | 2.60.40.1180 | |
| Domain | DnaJ_C | 1.68e-04 | 9 | 41 | 2 | IPR002939 | |
| Domain | DnaJ_C | 1.68e-04 | 9 | 41 | 2 | PF01556 | |
| Domain | HSP40/DnaJ_pept-bd | 1.68e-04 | 9 | 41 | 2 | IPR008971 | |
| Domain | - | 4.11e-04 | 449 | 41 | 6 | 3.30.40.10 | |
| Domain | Znf_RING/FYVE/PHD | 4.62e-04 | 459 | 41 | 6 | IPR013083 | |
| Domain | DnaJ_domain_CS | 1.59e-03 | 27 | 41 | 2 | IPR018253 | |
| Domain | Znf_FYVE_PHD | 4.09e-03 | 147 | 41 | 3 | IPR011011 | |
| Domain | F-box-like | 4.20e-03 | 44 | 41 | 2 | PF12937 | |
| Domain | RING | 4.39e-03 | 305 | 41 | 4 | SM00184 | |
| Domain | DnaJ | 4.98e-03 | 48 | 41 | 2 | PF00226 | |
| Domain | DNAJ_1 | 5.18e-03 | 49 | 41 | 2 | PS00636 | |
| Domain | DNAJ_2 | 5.18e-03 | 49 | 41 | 2 | PS50076 | |
| Domain | DnaJ | 5.18e-03 | 49 | 41 | 2 | SM00271 | |
| Domain | - | 5.18e-03 | 49 | 41 | 2 | 1.10.287.110 | |
| Domain | Znf_RING | 5.55e-03 | 326 | 41 | 4 | IPR001841 | |
| Domain | DnaJ_domain | 5.60e-03 | 51 | 41 | 2 | IPR001623 | |
| Domain | Sushi | 5.82e-03 | 52 | 41 | 2 | PF00084 | |
| Domain | FBOX | 5.82e-03 | 52 | 41 | 2 | SM00256 | |
| Domain | SOLCAR | 6.04e-03 | 53 | 41 | 2 | PS50920 | |
| Domain | - | 6.04e-03 | 53 | 41 | 2 | 1.50.40.10 | |
| Domain | Mitochondrial_sb/sol_carrier | 6.04e-03 | 53 | 41 | 2 | IPR018108 | |
| Domain | Mito_carr | 6.04e-03 | 53 | 41 | 2 | PF00153 | |
| Domain | Mt_carrier_dom | 6.04e-03 | 53 | 41 | 2 | IPR023395 | |
| Domain | CCP | 6.26e-03 | 54 | 41 | 2 | SM00032 | |
| Domain | Znf_C3HC4_RING-type | 6.33e-03 | 172 | 41 | 3 | IPR018957 | |
| Domain | SUSHI | 6.72e-03 | 56 | 41 | 2 | PS50923 | |
| Domain | Sushi_SCR_CCP_dom | 6.95e-03 | 57 | 41 | 2 | IPR000436 | |
| Domain | UBA-like | 8.70e-03 | 64 | 41 | 2 | IPR009060 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GLYCOGEN_DEGRADATION_AMYLASE_ | 5.44e-12 | 9 | 32 | 5 | M47622 | |
| Pathway | REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE | 1.99e-11 | 11 | 32 | 5 | M1091 | |
| Pathway | REACTOME_DIGESTION | 1.42e-09 | 23 | 32 | 5 | M27790 | |
| Pathway | REACTOME_DIGESTION_AND_ABSORPTION | 4.11e-09 | 28 | 32 | 5 | M27837 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 1.05e-07 | 52 | 32 | 5 | M14171 | |
| Pathway | REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE | 5.90e-07 | 8 | 32 | 3 | MM14717 | |
| Pathway | REACTOME_DIGESTION | 1.37e-05 | 21 | 32 | 3 | MM15526 | |
| Pathway | REACTOME_DIGESTION_AND_ABSORPTION | 2.36e-05 | 25 | 32 | 3 | MM15557 | |
| Pubmed | Regional assignment of human amylase (AMY) to p22----p21 of chromosome 1. | 1.73e-14 | 6 | 45 | 5 | 6608795 | |
| Pubmed | 1.73e-14 | 6 | 45 | 5 | 2081604 | ||
| Pubmed | 1.73e-14 | 6 | 45 | 5 | 15286789 | ||
| Pubmed | 1.73e-14 | 6 | 45 | 5 | 2452973 | ||
| Pubmed | The human alpha-amylase multigene family consists of haplotypes with variable numbers of genes. | 1.73e-14 | 6 | 45 | 5 | 2788608 | |
| Pubmed | 6.04e-14 | 7 | 45 | 5 | 8604219 | ||
| Pubmed | 1.61e-13 | 8 | 45 | 5 | 12414807 | ||
| Pubmed | Low Copy Number of the AMY1 Locus Is Associated with Early-Onset Female Obesity in Finland. | 2.44e-12 | 4 | 45 | 4 | 26132294 | |
| Pubmed | Characterization of the amino termini of mouse salivary and pancreatic amylases. | 2.44e-12 | 4 | 45 | 4 | 6165618 | |
| Pubmed | Multiple polyadenylation sites in a mouse alpha-amylase gene. | 2.44e-12 | 4 | 45 | 4 | 6166922 | |
| Pubmed | A single mouse alpha-amylase gene specifies two different tissue-specific mRNAs. | 2.44e-12 | 4 | 45 | 4 | 6162570 | |
| Pubmed | Additional evidence for the close linkage of amy-1 and amy-2 in the mouse. | 2.44e-12 | 4 | 45 | 4 | 6163812 | |
| Pubmed | Structural forms of the human amylase locus and their relationships to SNPs, haplotypes and obesity. | 2.44e-12 | 4 | 45 | 4 | 26098870 | |
| Pubmed | 2.44e-12 | 4 | 45 | 4 | 6160849 | ||
| Pubmed | Members of the Amy-2 alpha-amylase gene family of mouse strain CE/J contain duplicated 5' termini. | 2.44e-12 | 4 | 45 | 4 | 2987507 | |
| Pubmed | Electrophoretic variation of alpha-amylase in two inbred strains of Mus musculus. | 2.44e-12 | 4 | 45 | 4 | 4745489 | |
| Pubmed | 2.44e-12 | 4 | 45 | 4 | 6091898 | ||
| Pubmed | Gentic polymorphism of amylase isoenzymes in feral populations of the house mouse. | 2.44e-12 | 4 | 45 | 4 | 1141004 | |
| Pubmed | Genetic variation in mouse salivary amylase rate of synthesis. | 2.44e-12 | 4 | 45 | 4 | 94264 | |
| Pubmed | Genetic regulation of GM4(NeuAc) expression in mouse erythrocytes. | 2.44e-12 | 4 | 45 | 4 | 2332419 | |
| Pubmed | 2.44e-12 | 4 | 45 | 4 | 3872721 | ||
| Pubmed | 2.44e-12 | 4 | 45 | 4 | 6157477 | ||
| Pubmed | 2.44e-12 | 4 | 45 | 4 | 6176715 | ||
| Pubmed | Mouse liver and salivary gland alpha-amylase mRNAs differ only in 5' non-translated sequences. | 2.44e-12 | 4 | 45 | 4 | 6162108 | |
| Pubmed | Simultaneous expression of salivary and pancreatic amylase genes in cultured mouse hepatoma cells. | 2.44e-12 | 4 | 45 | 4 | 2431276 | |
| Pubmed | 2.44e-12 | 4 | 45 | 4 | 16152770 | ||
| Pubmed | Independent regulation of nonallelic pancreatic amylase genes in diabetic mice. | 2.44e-12 | 4 | 45 | 4 | 6207174 | |
| Pubmed | 2.44e-12 | 4 | 45 | 4 | 2423416 | ||
| Pubmed | 2.44e-12 | 4 | 45 | 4 | 2410924 | ||
| Pubmed | 2.44e-12 | 4 | 45 | 4 | 2476716 | ||
| Pubmed | 2.44e-12 | 4 | 45 | 4 | 6161122 | ||
| Pubmed | Expression of mouse Amy-2a alpha-amylase genes is regulated by strong pancreas-specific promoters. | 2.44e-12 | 4 | 45 | 4 | 3877171 | |
| Pubmed | Mouse alpha-amylase loci, Amy-1a and Amy-2a, are closely linked. | 2.44e-12 | 4 | 45 | 4 | 2989529 | |
| Pubmed | Genetic mapping of the IL-12 alpha chain gene (Il12a) on mouse chromosome 3. | 1.22e-11 | 5 | 45 | 4 | 8661735 | |
| Pubmed | 1.22e-11 | 5 | 45 | 4 | 6529441 | ||
| Pubmed | Murine Salivary Amylase Protects Against Streptococcus mutans-Induced Caries. | 1.22e-11 | 5 | 45 | 4 | 34276419 | |
| Pubmed | 1.22e-11 | 5 | 45 | 4 | 6176569 | ||
| Pubmed | 1.22e-11 | 5 | 45 | 4 | 1348427 | ||
| Pubmed | 3.66e-11 | 6 | 45 | 4 | 7946325 | ||
| Pubmed | Ampd-2 maps to distal mouse chromosome 3 in linkage with Ampd-1. | 3.66e-11 | 6 | 45 | 4 | 2328996 | |
| Pubmed | Genetics of hydroxyacid oxidase isozymes in the mouse: localisation of Hao-2 on linkage group XVI. | 3.66e-11 | 6 | 45 | 4 | 284003 | |
| Pubmed | A fibrillar collagen gene, Col11a1, is essential for skeletal morphogenesis. | 3.66e-11 | 6 | 45 | 4 | 7859283 | |
| Pubmed | 3.66e-11 | 6 | 45 | 4 | 2002257 | ||
| Pubmed | 3.66e-11 | 6 | 45 | 4 | 2450406 | ||
| Pubmed | The mouse urate oxidase gene, Uox, maps to distal chromosome 3. | 3.66e-11 | 6 | 45 | 4 | 9250879 | |
| Pubmed | Linkage of the cadmium resistance locus to loci on mouse chromosome 12. | 3.66e-11 | 6 | 45 | 4 | 1021597 | |
| Pubmed | 8.53e-11 | 7 | 45 | 4 | 6160178 | ||
| Pubmed | Rostral cerebellar malformation, (rcm): a new recessive mutation on chromosome 3 of the mouse. | 8.53e-11 | 7 | 45 | 4 | 1401878 | |
| Pubmed | Analysis of the mouse Amy locus in recombinant inbred mouse strains. | 8.53e-11 | 7 | 45 | 4 | 2451911 | |
| Pubmed | 8.53e-11 | 7 | 45 | 4 | 8666240 | ||
| Pubmed | 8.53e-11 | 7 | 45 | 4 | 7949740 | ||
| Pubmed | 1.70e-10 | 8 | 45 | 4 | 2824476 | ||
| Pubmed | Linkage relationships among eleven biochemical loci in Peromyscus. | 1.70e-10 | 8 | 45 | 4 | 6200103 | |
| Pubmed | 1.70e-10 | 8 | 45 | 4 | 8486361 | ||
| Pubmed | Murine VCAM-1. Molecular cloning, mapping, and analysis of a truncated form. | 1.70e-10 | 8 | 45 | 4 | 7523515 | |
| Pubmed | 1.70e-10 | 8 | 45 | 4 | 2040456 | ||
| Pubmed | 1.70e-10 | 8 | 45 | 4 | 3038891 | ||
| Pubmed | 3.07e-10 | 9 | 45 | 4 | 93520 | ||
| Pubmed | 5.10e-10 | 10 | 45 | 4 | 9121556 | ||
| Pubmed | 5.10e-10 | 10 | 45 | 4 | 2897103 | ||
| Pubmed | Mouse R-cadherin: expression during the organogenesis of pancreas and gastrointestinal tract. | 8.01e-10 | 11 | 45 | 4 | 7493641 | |
| Pubmed | 8.01e-10 | 11 | 45 | 4 | 23449223 | ||
| Pubmed | Four loci from human chromosome 1 are physically assigned to sheep chromosome 1p. | 8.01e-10 | 11 | 45 | 4 | 8589528 | |
| Pubmed | 8.01e-10 | 11 | 45 | 4 | 2903254 | ||
| Pubmed | 8.01e-10 | 11 | 45 | 4 | 2565740 | ||
| Pubmed | 8.01e-10 | 11 | 45 | 4 | 7608209 | ||
| Pubmed | 8.01e-10 | 11 | 45 | 4 | 1617215 | ||
| Pubmed | 1.20e-09 | 12 | 45 | 4 | 8144363 | ||
| Pubmed | Assignment of the mouse homologues of 6 loci from HSA1p to chromosomes 3 and 4. | 1.73e-09 | 13 | 45 | 4 | 7829080 | |
| Pubmed | 1.73e-09 | 13 | 45 | 4 | 489953 | ||
| Pubmed | 2.02e-09 | 3 | 45 | 3 | 15299664 | ||
| Pubmed | 2.02e-09 | 3 | 45 | 3 | 32697825 | ||
| Pubmed | The structure of two distinct pancreatic amylase genes in mouse strain YBR. | 2.02e-09 | 3 | 45 | 3 | 2413838 | |
| Pubmed | 2.02e-09 | 3 | 45 | 3 | 6098446 | ||
| Pubmed | 2.02e-09 | 3 | 45 | 3 | 12527308 | ||
| Pubmed | 2.02e-09 | 3 | 45 | 3 | 2414282 | ||
| Pubmed | 2.02e-09 | 3 | 45 | 3 | 8413315 | ||
| Pubmed | 2.02e-09 | 3 | 45 | 3 | 28659346 | ||
| Pubmed | 2.02e-09 | 3 | 45 | 3 | 6176528 | ||
| Pubmed | State and trait variance in salivary α-amylase: a behavioral genetic study. | 2.02e-09 | 3 | 45 | 3 | 21827821 | |
| Pubmed | 2.02e-09 | 3 | 45 | 3 | 30982860 | ||
| Pubmed | Report of the Committee on the Genetic Constitution of Chromosome 1. | 2.02e-09 | 3 | 45 | 3 | 6360562 | |
| Pubmed | 2.02e-09 | 3 | 45 | 3 | 22063648 | ||
| Pubmed | Tissue-specific and insulin-dependent expression of a pancreatic amylase gene in transgenic mice. | 2.02e-09 | 3 | 45 | 3 | 2436036 | |
| Pubmed | 2.02e-09 | 3 | 45 | 3 | 1699843 | ||
| Pubmed | Two distinct pancreatic amylase genes are active in YBR mice. | 2.02e-09 | 3 | 45 | 3 | 6180955 | |
| Pubmed | An insulin-responsive element in the pancreatic enhancer of the amylase gene. | 2.02e-09 | 3 | 45 | 3 | 7678001 | |
| Pubmed | 2.02e-09 | 3 | 45 | 3 | 25588701 | ||
| Pubmed | Comparative genomic analysis of the mouse and rat amylase multigene family. | 2.02e-09 | 3 | 45 | 3 | 17223109 | |
| Pubmed | 2.42e-09 | 14 | 45 | 4 | 2902233 | ||
| Pubmed | 2.42e-09 | 14 | 45 | 4 | 7894156 | ||
| Pubmed | Syntenic assignment of human chromosome 1 homologous loci in the bovine. | 2.42e-09 | 14 | 45 | 4 | 8001974 | |
| Pubmed | 4.40e-09 | 16 | 45 | 4 | 2571572 | ||
| Pubmed | 4.40e-09 | 16 | 45 | 4 | 10842072 | ||
| Pubmed | 5.75e-09 | 17 | 45 | 4 | 25410786 | ||
| Pubmed | 7.38e-09 | 18 | 45 | 4 | 34446743 | ||
| Pubmed | 7.38e-09 | 18 | 45 | 4 | 2338144 | ||
| Pubmed | An amylase/Cre transgene marks the whole endoderm but the primordia of liver and ventral pancreas. | 8.09e-09 | 4 | 45 | 3 | 16786601 | |
| Pubmed | 8.09e-09 | 4 | 45 | 3 | 20939500 | ||
| Pubmed | 8.09e-09 | 4 | 45 | 3 | 2458567 | ||
| Interaction | AMY2B interactions | 1.15e-06 | 10 | 44 | 3 | int:AMY2B | |
| Cytoband | 1p21 | 3.01e-11 | 24 | 45 | 5 | 1p21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p21 | 7.10e-08 | 107 | 45 | 5 | chr1p21 | |
| Cytoband | 5p13.1 | 1.42e-04 | 18 | 45 | 2 | 5p13.1 | |
| Cytoband | 2p21 | 1.66e-03 | 61 | 45 | 2 | 2p21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2p21 | 2.83e-03 | 80 | 45 | 2 | chr2p21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5p13 | 8.27e-03 | 139 | 45 | 2 | chr5p13 | |
| GeneFamily | Cyclins|F-boxes other | 1.54e-03 | 39 | 27 | 2 | 560 | |
| GeneFamily | DNAJ (HSP40) heat shock proteins|C2 tensin-type domain containing | 2.42e-03 | 49 | 27 | 2 | 584 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 3.26e-03 | 57 | 27 | 2 | 1179 | |
| GeneFamily | Ring finger proteins | 7.77e-03 | 275 | 27 | 3 | 58 | |
| Coexpression | LEE_AGING_MUSCLE_UP | 7.33e-07 | 41 | 45 | 4 | MM698 | |
| Coexpression | BERGER_MBD2_TARGETS | 7.73e-07 | 11 | 45 | 3 | MM905 | |
| Coexpression | CADWELL_ATG16L1_TARGETS_UP | 1.65e-06 | 116 | 45 | 5 | MM1240 | |
| Coexpression | MCCLUNG_CREB1_TARGETS_DN | 3.45e-06 | 60 | 45 | 4 | MM654 | |
| Coexpression | GSE3720_LPS_VS_PMA_STIM_VD2_GAMMADELTA_TCELL_UP | 3.74e-06 | 137 | 45 | 5 | M6346 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_DN | 8.32e-06 | 432 | 45 | 7 | M41149 | |
| Coexpression | IGLESIAS_E2F_TARGETS_DN | 1.34e-05 | 27 | 45 | 3 | MM643 | |
| Coexpression | SERVITJA_ISLET_HNF1A_TARGETS_UP | 1.61e-05 | 185 | 45 | 5 | MM1072 | |
| Coexpression | SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4 | 2.05e-05 | 330 | 45 | 6 | MM1120 | |
| Coexpression | LIAN_LIPA_TARGETS_6M | 2.34e-05 | 97 | 45 | 4 | MM1016 | |
| Coexpression | GSE17721_0.5H_VS_12H_POLYIC_BMDC_DN | 2.35e-05 | 200 | 45 | 5 | M4087 | |
| Coexpression | NAKAYA_MYELOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP | 5.91e-05 | 399 | 45 | 6 | M41172 | |
| Coexpression | MARTIN_NFKB_TARGETS_UP | 6.82e-05 | 46 | 45 | 3 | MM552 | |
| Coexpression | CHEBOTAEV_GR_TARGETS_DN | 7.80e-05 | 132 | 45 | 4 | MM470 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_PCA1_UP | 1.06e-04 | 143 | 45 | 4 | MM1056 | |
| Coexpression | OHGUCHI_LIVER_HNF4A_TARGETS_UP | 1.10e-04 | 54 | 45 | 3 | MM889 | |
| Coexpression | BORLAK_LIVER_CANCER_EGF_UP | 1.30e-04 | 57 | 45 | 3 | MM527 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | 1.38e-04 | 466 | 45 | 6 | M13522 | |
| Coexpression | LAKE_ADULT_KIDNEY_C27_VASCULAR_SMOOTH_MUSCLE_CELLS_AND_PERICYTES | 1.45e-04 | 155 | 45 | 4 | M39246 | |
| Coexpression | XIE_TRASTUZUMAB_CARDIOTOXICITY_MMU_MIR_483_5P_GENES | 1.57e-04 | 11 | 45 | 2 | MM17503 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 1.60e-04 | 300 | 45 | 5 | M8702 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP | 1.89e-04 | 166 | 45 | 4 | MM563 | |
| Coexpression | GSE22601_DOUBLE_NEGATIVE_VS_DOUBLE_POSITIVE_THYMOCYTE_DN | 3.84e-04 | 200 | 45 | 4 | M6246 | |
| Coexpression | GSE15659_NAIVE_VS_PTPRC_NEG_CD4_TCELL_DN | 3.84e-04 | 200 | 45 | 4 | M3538 | |
| Coexpression | SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN | 4.23e-04 | 85 | 45 | 3 | M7012 | |
| Coexpression | TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN | 4.29e-04 | 206 | 45 | 4 | M14134 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.54e-06 | 195 | 45 | 5 | 1cdf5f296029ae424d9dba42e86a6d111e4896e6 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMK+-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.15e-05 | 162 | 45 | 4 | 19395bdb282b4a2d88cd33191af12c24a88c3d16 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.15e-05 | 162 | 45 | 4 | 80317c4253bf8e897782e562f29835f181c65b98 | |
| ToppCell | normal-na-Lymphocytic_T-CytoT_GZMK+-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 3.46e-05 | 183 | 45 | 4 | 79defd22b3194dad16db55b9bdd220c09c1e6b90 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_T-CytoT_GZMK+-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.85e-05 | 188 | 45 | 4 | 2513ca0efa73c09a3406b99e2876982d78b173d7 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_T-CytoT_GZMK+-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.09e-05 | 191 | 45 | 4 | 752e31a4b8aab9243b0451f4c40c2940ae9a5252 | |
| ToppCell | normal-na-Lymphocytic_T-CytoT_GZMK+-female|normal / PBMC cell types (v2) per disease, treatment status, and sex | 4.09e-05 | 191 | 45 | 4 | 2ad34ccd55362db04511c90cf264ae5b93b48dde | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_T-CytoT_GZMK+|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.18e-05 | 192 | 45 | 4 | 71bc03b08cda0382ea45b503d5f4f135ed98cc11 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD8+_T-MAIT|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.18e-05 | 192 | 45 | 4 | 892789bdba150ef9a8a0012de52545f2ff6a31f6 | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-MAIT|COVID-19_Mild / Disease group, lineage and cell class | 4.18e-05 | 192 | 45 | 4 | d47bd132e57f5b4bddcf3dfa399cee149eca7e44 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD8+_T-MAIT-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.18e-05 | 192 | 45 | 4 | 24ea8fdcca2695aeb2e4b88161184124b7d332c1 | |
| ToppCell | normal-na-Lymphocytic_T-CytoT_GZMK+|normal / PBMC cell types (v2) per disease, treatment status, and sex | 4.18e-05 | 192 | 45 | 4 | 7460ce6e2f91bbf940b684f63231db7501ace09f | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD8+_T-MAIT-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.18e-05 | 192 | 45 | 4 | 44f440ee3842fe14665c4cd4f2aa48e7a5bbd9a8 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD8+_T-MAIT|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.18e-05 | 192 | 45 | 4 | 8d50ad8cfe3cb9f183188b08457756af0ce56ffe | |
| ToppCell | T/NK_cells-CD8+_Effector_T_cell|World / Lineage and Cell class | 4.26e-05 | 193 | 45 | 4 | 79fa0f482cd98642b1d38835cda98622f21e5bd0 | |
| ToppCell | ILEUM-inflamed-(8)_Smooth_muscle_cells|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.26e-05 | 193 | 45 | 4 | 084c88f08ce0ecd6c9f4334caed370eb2154f896 | |
| ToppCell | Healthy_donor-CD8+_Tem|Healthy_donor / disease group, cell group and cell class (v2) | 4.35e-05 | 194 | 45 | 4 | bf2e889de60b2b452a41f4d59a0f2a1865f07184 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD8-Trm_gut_CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 4.35e-05 | 194 | 45 | 4 | e9db509ff75f8605365841276fac6cec66ae27c7 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD8-Trm/em_CD8|bone_marrow / Manually curated celltypes from each tissue | 4.44e-05 | 195 | 45 | 4 | ed4e2275dac47cc9fb9c381e3f80fed0ce50b074 | |
| ToppCell | tumor_Lung-Fibroblasts-Smooth_muscle_cells|tumor_Lung / Location, Cell class and cell subclass | 4.44e-05 | 195 | 45 | 4 | ea9ff25020c2fcd1bab80e1829af0f4e4777de8b | |
| ToppCell | mild_COVID-19-CD4+_CTL|World / disease group, cell group and cell class (v2) | 4.44e-05 | 195 | 45 | 4 | 980909246c30471c9f2f97c3b20b6d6d20fe574e | |
| ToppCell | Healthy/Control-CD8+_Tem|Healthy/Control / Disease group and Cell class | 4.44e-05 | 195 | 45 | 4 | f4955c176c4918052dc151c5e5249223ec428272 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_cytotoxic-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.44e-05 | 195 | 45 | 4 | 5650975e98dacf4333373c8c04aff0a0944acc7c | |
| ToppCell | Healthy_donor-CD8+_Tem|World / disease group, cell group and cell class (v2) | 4.53e-05 | 196 | 45 | 4 | b04684d319d0c462862677d0f956a389bffef535 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.53e-05 | 196 | 45 | 4 | 7773735a570fa1c482654058245ddb364062e26d | |
| ToppCell | Healthy/Control-CD8+_Tem|World / Disease group and Cell class | 4.53e-05 | 196 | 45 | 4 | a6dc92476156a695e15373ea57dc04e30014ac55 | |
| ToppCell | severe_COVID-19-CD8+_Tem|World / disease group, cell group and cell class (v2) | 4.53e-05 | 196 | 45 | 4 | f0d3067b0f596dd84da2af4bf062fb9f04ef1dc4 | |
| ToppCell | Smart-seq2-bone_marrow_(Smart-seq2)-lymphocytic-T_lymphocytic|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.62e-05 | 197 | 45 | 4 | 895f18f6a82814653814a698104c59ecbaee5119 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.62e-05 | 197 | 45 | 4 | 0dd71e399f253787fa546a7e90c5373180b89ffd | |
| ToppCell | mild_COVID-19-CD8+_Tem|World / disease group, cell group and cell class (v2) | 4.62e-05 | 197 | 45 | 4 | 97fead264e986d922669a6006cbcec530c697df7 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.62e-05 | 197 | 45 | 4 | 888f3b14133e078570ce4ad73d9a9ee3137f9cac | |
| ToppCell | COVID-19_Moderate-CD8+_Tem|World / disease group, cell group and cell class | 4.71e-05 | 198 | 45 | 4 | 1d12be256af028c88e31fb535068bae16b7bd48e | |
| ToppCell | mild_COVID-19-CD8+_Tem|mild_COVID-19 / disease group, cell group and cell class (v2) | 4.71e-05 | 198 | 45 | 4 | 12847340c36a6791d8bdcb81e731e2fdeec46326 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.71e-05 | 198 | 45 | 4 | cc162ba4b3b8dec667a8cffd3411965f3f856f8c | |
| ToppCell | severe_COVID-19-CD8+_Tem|severe_COVID-19 / disease group, cell group and cell class (v2) | 4.71e-05 | 198 | 45 | 4 | 69d49f37cf5095e65c71cddc6d43748322ff19a3 | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblasts|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.80e-05 | 199 | 45 | 4 | 3a3e2bb21cd0293622b1a975263e918d9ba24265 | |
| ToppCell | Caecum-(1)_T_cell|Caecum / shred on region, Cell_type, and subtype | 4.80e-05 | 199 | 45 | 4 | 9e8d121550d60091d82f236d7c67361291aaf0e0 | |
| ToppCell | ILEUM-non-inflamed-(8)_Fibroblasts|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.80e-05 | 199 | 45 | 4 | d9d7f36b4b5592b7855448730044c90997b55499 | |
| ToppCell | Caecum-T_cell|Caecum / Region, Cell class and subclass | 4.80e-05 | 199 | 45 | 4 | 4971ba943256f6390dffabf43e45d4e86ce94b46 | |
| ToppCell | Caecum-(1)_T_cell-(12)_Th1|Caecum / shred on region, Cell_type, and subtype | 4.89e-05 | 200 | 45 | 4 | 61328a95966191aec378fa4cd2a083734354b03c | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-CD8+_Tem|COVID-19_Mild / Disease, condition lineage and cell class | 4.89e-05 | 200 | 45 | 4 | 7ea4f439f03099da474ac8c04a07bbbde77dafc6 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-MAIT|COVID-19_Severe / Disease, condition lineage and cell class | 4.89e-05 | 200 | 45 | 4 | b8cfccecff9900aee323c40e771c94e560b8c488 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.89e-05 | 200 | 45 | 4 | fee22a6a6c7b93af204b5b56f2c34f1411500e18 | |
| ToppCell | Sigmoid-T_cell-Th1|Sigmoid / Region, Cell class and subclass | 4.89e-05 | 200 | 45 | 4 | dabc496d87ce696501556e92a265680c4bd0c1c2 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-MAIT|COVID-19_Mild / Disease, condition lineage and cell class | 4.89e-05 | 200 | 45 | 4 | 45b2a84d5a325f551205ae31c164d2de7773d3b6 | |
| ToppCell | Sigmoid-(1)_T_cell-(12)_Th1|Sigmoid / shred on region, Cell_type, and subtype | 4.89e-05 | 200 | 45 | 4 | 271204b12423f5e895c80caf17bf31faa5099a9f | |
| ToppCell | Caecum-T_cell-Th1|Caecum / Region, Cell class and subclass | 4.89e-05 | 200 | 45 | 4 | cfa2e8a6230a8a7b43d2c89fd464cb8b4ca79589 | |
| ToppCell | ILEUM-non-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.42e-04 | 135 | 45 | 3 | b7a792a7c0c22d8b703509f134115f0e394d7de0 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 4.56e-04 | 149 | 45 | 3 | 768877bade04ca0321593b8470b5011ad8270431 | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_large-bowel / Manually curated celltypes from each tissue | 4.83e-04 | 152 | 45 | 3 | 95944864ce7539ff8de028f5700694931338f3ff | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 5.02e-04 | 154 | 45 | 3 | 65dbb60f636562eeba3dafadae9c0c7db2b27476 | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_11|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.02e-04 | 154 | 45 | 3 | 5967a0a33456d5930fc492a700ebb015ac050abb | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_11|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.12e-04 | 155 | 45 | 3 | fab281db4c275d51240b122be78713c839ba5a95 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 5.21e-04 | 156 | 45 | 3 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | severe_COVID-19-MAIT|severe_COVID-19 / disease group, cell group and cell class (v2) | 5.31e-04 | 157 | 45 | 3 | 175f637e9707836bd63b5c2ccc9d4eb601c05b9e | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Lymphocytic-Epcam____proximal_tube_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.41e-04 | 158 | 45 | 3 | 1d78578dc1f8ba43dacdccae1082c0b9d749f64d | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-1|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.41e-04 | 158 | 45 | 3 | cf1b77abd05f18526679c0d305b4dd2caef2b306 | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Dendritic-DC1|bone_marrow / Manually curated celltypes from each tissue | 5.72e-04 | 161 | 45 | 3 | 2f068ee643de2f647c289779a6624265ab9a749b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c04-ANXA2|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.03e-04 | 164 | 45 | 3 | 8f3255d7f67890389a768453492243ea982eb38a | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Lymphocytic-mature_NK_T_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.03e-04 | 164 | 45 | 3 | 22f37c39fdce2cf6dc72c6db619537d4b0234839 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-T_cells-Th1|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.36e-04 | 167 | 45 | 3 | 9c55ec8f70b86d4d3d5c2a6ecd9bff2dafe68c11 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.36e-04 | 167 | 45 | 3 | abc4ba308ca3be41b0da604f5d82579fd58dff7b | |
| ToppCell | 368C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 6.58e-04 | 169 | 45 | 3 | 58098f8801ca941aeddafb47e88ab0df8b9edb57 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-B_(Myofibroblast)|368C / Donor, Lineage, Cell class and subclass (all cells) | 6.58e-04 | 169 | 45 | 3 | 1d5ce2c97f7ef7bdc9f861938077a9aa31d84db6 | |
| ToppCell | COVID-19_Severe-Treg|COVID-19_Severe / disease group, cell group and cell class | 6.69e-04 | 170 | 45 | 3 | d61269a51283125835884c4aa50623756c4fdda2 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 6.81e-04 | 171 | 45 | 3 | bdd30100b74e012eec3090799c22635aa57fa91d | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 6.81e-04 | 171 | 45 | 3 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.04e-04 | 173 | 45 | 3 | e1378201b15ffb98e196ac39fe3ee4b4078953bd | |
| ToppCell | Bac-SEP-Myeloid-cDC1|Bac-SEP / Disease, Lineage and Cell Type | 7.04e-04 | 173 | 45 | 3 | f88269327441858ddb8c49b9dd619b76fd53b1da | |
| ToppCell | URO-Myeloid-cDC1|URO / Disease, Lineage and Cell Type | 7.04e-04 | 173 | 45 | 3 | 57f4e9f39ef6e02dca76f3dd0b39a0871917ed5a | |
| ToppCell | facs-Large_Intestine-Proximal-3m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.04e-04 | 173 | 45 | 3 | 99532bb768ee35fed939a377acb5215d3f8904bd | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.28e-04 | 175 | 45 | 3 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.28e-04 | 175 | 45 | 3 | e99e145a152f534b75267ec492a252a0b814b4f8 | |
| ToppCell | Pericytes-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 7.28e-04 | 175 | 45 | 3 | ddf721023a7afc8085c5de17aa254a6575444c0f | |
| ToppCell | 390C-Fibroblasts-Fibroblast-B_(Myofibroblast)|390C / Donor, Lineage, Cell class and subclass (all cells) | 7.40e-04 | 176 | 45 | 3 | 852d3da0907fe87c0ef23d75a63ce07619cf0c54 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 7.40e-04 | 176 | 45 | 3 | d2df1e435996c51213e88270af9f928e9e09a6f5 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_3|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 7.52e-04 | 177 | 45 | 3 | 3d955ea938a1d2fb1b6d68d4997fd454bd632dfc | |
| ToppCell | 343B-Fibroblasts-Fibroblast-B_(Myofibroblast)|343B / Donor, Lineage, Cell class and subclass (all cells) | 7.52e-04 | 177 | 45 | 3 | e55d21d4d61a069b9bbe0e7595fbfb7cfbacfd87 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_NK-T_mait-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 7.52e-04 | 177 | 45 | 3 | 605f71515c877bb4de4121675ec8c1318a2500a7 | |
| ToppCell | IIH-CD8-antiviral_CD4|IIH / Condition, Cell_class and T cell subcluster | 7.52e-04 | 177 | 45 | 3 | fe73608c40701eca88b260aeb5c0640d7bee72ba | |
| ToppCell | 343B-Fibroblasts-Fibroblast-B_(Myofibroblast)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 7.52e-04 | 177 | 45 | 3 | 43ba6f12c2fb32698a420bf799d46ac1b558f146 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.77e-04 | 179 | 45 | 3 | b70509288aaf4457afd350f6c45784521337ce0d | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_A|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.82e-04 | 41 | 45 | 2 | 9f609afcf34f0b486dfe51e5f0e903fe357d3e91 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-G|390C / Donor, Lineage, Cell class and subclass (all cells) | 7.90e-04 | 180 | 45 | 3 | 137fc14859c89e1ecd98bee388bb58c04b835847 | |
| ToppCell | renal_papilla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 7.90e-04 | 180 | 45 | 3 | 49829e833fe6d2431cfd2e8f378c2aaa3b2b46a4 | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Dendritic-DC1|lymph-node_spleen / Manually curated celltypes from each tissue | 7.90e-04 | 180 | 45 | 3 | a7db1f00566c9acab8b239cbf2e053fb3f2f6a0d | |
| ToppCell | MatrixFB-Fibroblast-A|MatrixFB / shred on cell class and cell subclass (v4) | 7.90e-04 | 180 | 45 | 3 | adc64ad6033af705dd7b9163a83e20ef5c59f6eb | |
| ToppCell | 390C-Fibroblasts-Fibroblast-G-|390C / Donor, Lineage, Cell class and subclass (all cells) | 7.90e-04 | 180 | 45 | 3 | cd6790de050151fedfa2c5ea6ad58b72665414b2 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.02e-04 | 181 | 45 | 3 | 2b53a65ca5616a7b9f64232c3e0b7212d1e2f063 | |
| ToppCell | droplet-Marrow-BM|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.02e-04 | 181 | 45 | 3 | 4169a1527b9c8f5783b8cc44e3a3924f8ed9a5e2 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.02e-04 | 181 | 45 | 3 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.02e-04 | 181 | 45 | 3 | 6aef84616e8d2faf54b7e9e6cd02f33c3066dabc | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-Ciliated|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 8.02e-04 | 181 | 45 | 3 | 8eed9d46d924b16f6dd1a025ff612244b02b4391 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte-Ionocyte_L.0.7.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.02e-04 | 181 | 45 | 3 | 40df0afcb6848202da54670e84f22d7c3a515d01 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.02e-04 | 181 | 45 | 3 | 40d3829ae4aaf81e8616c3499ff8933137fc1cc4 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-MAIT-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.15e-04 | 182 | 45 | 3 | f30e5a21b49f30b82e2b6f1fd2daefd805a40083 | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-MAIT|COVID-19_Severe / Disease group, lineage and cell class | 8.15e-04 | 182 | 45 | 3 | 19045db5c726c06ec6e4feb4311633c8164ddb3c | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-MAIT|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.15e-04 | 182 | 45 | 3 | 1444cdc4522a70a40d697ccadf54cf26d327ade0 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-MAIT-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.15e-04 | 182 | 45 | 3 | cccac9f85825f4e310b86e37ee6320769a670501 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-MAIT|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.15e-04 | 182 | 45 | 3 | 49eced222e8f90c2b59bcc7d56b62c3e703fcce5 | |
| Drug | 4,6-O-3-ketobutylidene maltopentaose | 1.28e-13 | 6 | 44 | 5 | CID003083414 | |
| Drug | CNP-G3 | 1.28e-13 | 6 | 44 | 5 | CID003082910 | |
| Drug | R 623 | 1.28e-13 | 6 | 44 | 5 | CID003027594 | |
| Drug | dimethylaminomethylferrocene | 1.28e-13 | 6 | 44 | 5 | CID000102082 | |
| Drug | mono-6-deoxy-6-fluorocyclomaltoheptaose | 1.28e-13 | 6 | 44 | 5 | CID000127364 | |
| Drug | BG5P | 4.46e-13 | 7 | 44 | 5 | CID003082752 | |
| Drug | AC1L5BOU | 4.46e-13 | 7 | 44 | 5 | CID000174858 | |
| Drug | desethylaprophen | 1.19e-12 | 8 | 44 | 5 | CID000163919 | |
| Drug | azintamide | 1.19e-12 | 8 | 44 | 5 | CID000071105 | |
| Drug | alpha-maltosyl fluoride | 2.67e-12 | 9 | 44 | 5 | CID000194237 | |
| Drug | trestatin A | 2.67e-12 | 9 | 44 | 5 | CID003054994 | |
| Drug | AC1LAC07 | 5.33e-12 | 10 | 44 | 5 | CID000485275 | |
| Drug | AC1L3M0Q | 5.33e-12 | 10 | 44 | 5 | CID000118008 | |
| Drug | Glc)4 | 5.33e-12 | 10 | 44 | 5 | CID000189098 | |
| Drug | eicosa-11,14-dienoic acid | 5.33e-12 | 10 | 44 | 5 | CID000003208 | |
| Drug | CG-120 | 5.33e-12 | 10 | 44 | 5 | CID000171403 | |
| Drug | Ro 20-0083 | 5.33e-12 | 10 | 44 | 5 | CID003082332 | |
| Drug | validamycin D | 9.76e-12 | 11 | 44 | 5 | CID000166726 | |
| Drug | HgI2 | 9.76e-12 | 11 | 44 | 5 | CID000024485 | |
| Drug | 2C KM | 9.76e-12 | 11 | 44 | 5 | CID009549196 | |
| Drug | FG5P | 9.76e-12 | 11 | 44 | 5 | CID000127486 | |
| Drug | CNP-G5 | 9.76e-12 | 11 | 44 | 5 | CID000127309 | |
| Drug | Dembrexine | 1.21e-11 | 4 | 44 | 4 | CID000072009 | |
| Drug | g lw | 1.21e-11 | 4 | 44 | 4 | CID000444139 | |
| Drug | AC1MQT4V | 1.21e-11 | 4 | 44 | 4 | CID003482066 | |
| Drug | beta-santalene | 1.21e-11 | 4 | 44 | 4 | CID000010534 | |
| Drug | 2-nitropropyl acetate | 1.21e-11 | 4 | 44 | 4 | CID013573844 | |
| Drug | N-PMT | 1.21e-11 | 4 | 44 | 4 | CID000194224 | |
| Drug | SAIB-SG | 1.21e-11 | 4 | 44 | 4 | CID002735139 | |
| Drug | azaprophen | 1.67e-11 | 12 | 44 | 5 | CID000129486 | |
| Drug | methyl 1'-epiacarviosin | 2.71e-11 | 13 | 44 | 5 | CID000197426 | |
| Drug | isoacarbose | 2.71e-11 | 13 | 44 | 5 | CID000449165 | |
| Drug | Cyclodextrins | 4.21e-11 | 14 | 44 | 5 | CID000024238 | |
| Drug | terephthaloyl chloride | 4.21e-11 | 14 | 44 | 5 | CID000007488 | |
| Drug | 2-chloro-4-nitrophenol | 4.21e-11 | 14 | 44 | 5 | CID000012074 | |
| Drug | cimicifugic acid A | 6.06e-11 | 5 | 44 | 4 | CID006449879 | |
| Drug | silver perchlorate | 6.06e-11 | 5 | 44 | 4 | CID000024562 | |
| Drug | actinidine | 6.06e-11 | 5 | 44 | 4 | CID000068231 | |
| Drug | Deposiston | 6.06e-11 | 5 | 44 | 4 | CID003080829 | |
| Drug | lunularic acid | 6.06e-11 | 5 | 44 | 4 | CID000161413 | |
| Drug | 2-[[(2-amino-1,3-thiazol-4-yl)-(2-oxoethylcarbamoyl)methylidene]amino]oxy-2-methyl-propanoic Acid | 6.06e-11 | 5 | 44 | 4 | CID010358258 | |
| Drug | himachalene | 6.06e-11 | 5 | 44 | 4 | CID000015095 | |
| Drug | 2TAA | 6.06e-11 | 5 | 44 | 4 | CID000127374 | |
| Drug | AC1L4DZ4 | 6.06e-11 | 5 | 44 | 4 | CID000155287 | |
| Drug | 4-nitrophenylmaltoheptaoside | 6.31e-11 | 15 | 44 | 5 | CID000173254 | |
| Drug | gamma-cyclodextrin | 9.16e-11 | 16 | 44 | 5 | CID000086575 | |
| Drug | Bay e 4609 | 9.16e-11 | 16 | 44 | 5 | CID003085308 | |
| Drug | trimitan | 1.79e-10 | 18 | 44 | 5 | CID000005561 | |
| Drug | aprophen | 1.79e-10 | 18 | 44 | 5 | CID000071128 | |
| Drug | (2S)-2-acetamido-3-[(3E)-3-[(4-arsonophenyl)hydrazono]-4-oxo-cyclohexa-1,5-dien-1-yl]propanoic acid | 1.81e-10 | 6 | 44 | 4 | CID009577343 | |
| Drug | Borane dimethylamine complex | 1.81e-10 | 6 | 44 | 4 | CID009898794 | |
| Drug | AC1L3OV4 | 1.81e-10 | 6 | 44 | 4 | CID000092801 | |
| Drug | 2-amino-6-picoline | 1.81e-10 | 6 | 44 | 4 | CID000015765 | |
| Drug | phenol blue | 1.81e-10 | 6 | 44 | 4 | CID000075078 | |
| Drug | AC1OAGH8 | 1.81e-10 | 6 | 44 | 4 | CID006857368 | |
| Drug | vermella | 1.81e-10 | 6 | 44 | 4 | CID000203726 | |
| Drug | Gu-4 | 1.81e-10 | 6 | 44 | 4 | CID000448679 | |
| Drug | hymenin | 1.81e-10 | 6 | 44 | 4 | CID000010499 | |
| Drug | mercuric thiocyanate | 1.81e-10 | 6 | 44 | 4 | CID000011615 | |
| Drug | Paramax | 4.23e-10 | 7 | 44 | 4 | CID000156411 | |
| Drug | 3KBG5CNP | 4.23e-10 | 7 | 44 | 4 | CID003083250 | |
| Drug | AC1L9UU3 | 4.23e-10 | 7 | 44 | 4 | CID000071762 | |
| Drug | methyl blue | 4.23e-10 | 7 | 44 | 4 | CID011969534 | |
| Drug | amino-methyl | 4.23e-10 | 7 | 44 | 4 | CID000142005 | |
| Drug | AC1L3XPY | 4.24e-10 | 21 | 44 | 5 | CID000124005 | |
| Drug | maltosaccharide | 5.48e-10 | 22 | 44 | 5 | CID005461034 | |
| Drug | boric acid gel | 8.44e-10 | 8 | 44 | 4 | CID003016474 | |
| Drug | AC1NSVJM | 8.44e-10 | 8 | 44 | 4 | CID005317411 | |
| Drug | theodrenaline | 8.44e-10 | 8 | 44 | 4 | CID000071857 | |
| Drug | rhodanile blue | 8.44e-10 | 8 | 44 | 4 | CID000073372 | |
| Drug | N-vinylcaprolactam | 8.44e-10 | 8 | 44 | 4 | CID000075227 | |
| Drug | 9-azidoacridine | 8.44e-10 | 8 | 44 | 4 | CID000146692 | |
| Drug | acrinor | 8.44e-10 | 8 | 44 | 4 | CID005489637 | |
| Drug | NSC300622 | 8.44e-10 | 8 | 44 | 4 | CID000028426 | |
| Drug | Panose B | 8.81e-10 | 24 | 44 | 5 | CID000439297 | |
| Drug | CID439354 | 1.10e-09 | 25 | 44 | 5 | CID000439354 | |
| Drug | Atonik | 1.52e-09 | 9 | 44 | 4 | CID000069471 | |
| Drug | GSAD | 1.52e-09 | 9 | 44 | 4 | CID009909127 | |
| Drug | zingiberene | 1.52e-09 | 9 | 44 | 4 | CID000092776 | |
| Drug | H 187 | 1.52e-09 | 9 | 44 | 4 | CID000001742 | |
| Drug | GU-3 | 1.52e-09 | 9 | 44 | 4 | CID000448687 | |
| Drug | mercuric nitrate | 1.52e-09 | 9 | 44 | 4 | CID000024864 | |
| Drug | Sudan black B | 2.52e-09 | 64 | 44 | 6 | CID000061336 | |
| Drug | I ZE | 2.53e-09 | 10 | 44 | 4 | CID009549200 | |
| Drug | trans-cinnamamide | 2.53e-09 | 10 | 44 | 4 | CID000012135 | |
| Drug | UDP-pyridoxal | 2.53e-09 | 10 | 44 | 4 | CID000126789 | |
| Drug | naphthalene-1,3,6,8-tetrol | 2.53e-09 | 10 | 44 | 4 | CID000440202 | |
| Drug | N,N'-disalicylidene-1,3-diaminopropane | 2.93e-09 | 30 | 44 | 5 | CID005373003 | |
| Drug | Tempamine | 3.96e-09 | 11 | 44 | 4 | CID000550942 | |
| Drug | L-tert-leucine | 3.96e-09 | 11 | 44 | 4 | CID000164608 | |
| Drug | AMO-1618 | 3.96e-09 | 11 | 44 | 4 | CID000017103 | |
| Drug | AC1L8PXO | 3.96e-09 | 11 | 44 | 4 | CID000430710 | |
| Drug | Folin Marenzi reagent | 4.13e-09 | 32 | 44 | 5 | CID000452313 | |
| Drug | AC1L2K9S | 4.13e-09 | 32 | 44 | 5 | CID000073671 | |
| Drug | R625 | 4.86e-09 | 33 | 44 | 5 | CID000072375 | |
| Drug | AC1L4W0B | 5.94e-09 | 12 | 44 | 4 | CID000193311 | |
| Drug | chitosan | 5.94e-09 | 12 | 44 | 4 | CID000071853 | |
| Drug | 3-hydr-oxy-2-naphthohydrazide | 5.94e-09 | 12 | 44 | 4 | CID000072699 | |
| Drug | H2folate | 5.94e-09 | 12 | 44 | 4 | CID000168809 | |
| Drug | chloroisocyanuric acid | 5.94e-09 | 12 | 44 | 4 | CID000017921 | |
| Disease | alpha-amylase 1 measurement | 5.91e-10 | 9 | 45 | 4 | EFO_0801371 | |
| Disease | level of Phosphatidylcholine (18:1_20:3) in blood serum | 3.40e-05 | 6 | 45 | 2 | OBA_2045103 | |
| Disease | linoleoyl-arachidonoyl-glycerol (18:2/20:4) [1] measurement | 1.02e-04 | 10 | 45 | 2 | EFO_0800499 | |
| Disease | linoleoyl-arachidonoyl-glycerol (18:2/20:4) [2] measurement | 1.49e-04 | 12 | 45 | 2 | EFO_0800500 | |
| Disease | level of triacylglycerol (56:6) in blood serum | 2.69e-04 | 16 | 45 | 2 | OBA_2020007 | |
| Disease | triacylglycerol 52:6 measurement | 6.67e-04 | 25 | 45 | 2 | EFO_0010418 | |
| Disease | level of Sterol ester (27:1/16:0) in blood serum | 7.22e-04 | 26 | 45 | 2 | OBA_2045191 | |
| Disease | triacylglycerol 56:7 measurement | 8.99e-04 | 29 | 45 | 2 | EFO_0010434 | |
| Disease | Brain Tumor, Primary | 1.17e-03 | 33 | 45 | 2 | C0750974 | |
| Disease | Primary malignant neoplasm of brain | 1.17e-03 | 33 | 45 | 2 | C0750979 | |
| Disease | Recurrent Brain Neoplasm | 1.17e-03 | 33 | 45 | 2 | C0750977 | |
| Disease | Neoplasms, Intracranial | 1.17e-03 | 33 | 45 | 2 | C1527390 | |
| Disease | Benign neoplasm of brain, unspecified | 1.17e-03 | 33 | 45 | 2 | C0496899 | |
| Disease | triacylglycerol 56:8 measurement | 1.39e-03 | 36 | 45 | 2 | EFO_0010435 | |
| Disease | Malignant neoplasm of brain | 1.54e-03 | 38 | 45 | 2 | C0153633 | |
| Disease | Brain Neoplasms | 1.63e-03 | 39 | 45 | 2 | C0006118 | |
| Disease | cholesteryl esters to total lipids in small LDL percentage | 1.88e-03 | 42 | 45 | 2 | EFO_0022255 | |
| Disease | colorectal health | 3.58e-03 | 201 | 45 | 3 | EFO_0008460 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DLGFQQGADTQRRFK | 156 | P05156 | |
| LDFEKFLQQTGGRQG | 151 | Q8NEF3 | |
| KGQGFGQFGFQRLDL | 3376 | Q7Z408 | |
| KSGFASGRNFGNRDA | 56 | Q9NQI0 | |
| QVAFGRGNRGFIVFN | 431 | P0DTE7 | |
| QVAFGRGNRGFIVFN | 431 | P0DTE8 | |
| QVAFGRGNRGFIVFN | 431 | P0DUB6 | |
| QVAFGRGNRGFIVFN | 431 | P19961 | |
| GDYFRQRLKGQENGQ | 341 | A4D256 | |
| FGGRNPFDTFFGQRN | 106 | P25685 | |
| GKRGQNGFKEFTRQE | 746 | Q9NRL2 | |
| RFRQDGNEAVGGFFS | 211 | O75323 | |
| LASQGFDFNKVFRNG | 116 | O95453 | |
| QVAFGRGNRGFIVFN | 431 | P04746 | |
| FNKGLERTIRDNFGG | 56 | Q96HD1 | |
| FVQQKGQRFGLGSLA | 46 | Q86UW9 | |
| KTEQLRRNGFGKNGF | 421 | Q9HC44 | |
| RRNGFGKNGFLQSRS | 426 | Q9HC44 | |
| RFFLGNQFGDSQQLR | 7306 | Q03001 | |
| RQGQAKRLGLDEFNF | 396 | Q02156 | |
| GRARGNSFTKFGNRN | 391 | Q96PV6 | |
| FPNGQFQGDNFRITK | 161 | Q13191 | |
| GGKRTDFLQFQNLRN | 116 | Q8WWQ2 | |
| GLQEFLDRNSQFAGG | 716 | O75694 | |
| GRNLIFNSCGEQGFR | 106 | Q96EF6 | |
| LFGFMGNQSRSRNGR | 96 | O60884 | |
| NLFRFNKERAEGGQG | 51 | Q9Y2I7 | |
| FQNAGAQGRGKSFGI | 771 | Q9BX69 | |
| LEGNQIFNNRFGGLF | 791 | Q86XK2 | |
| LKNNGDFFIANEGRR | 396 | Q96EZ8 | |
| SRNFILRGTFNDGFQ | 571 | Q9HC35 | |
| DGSFNIGQRRFNLQK | 171 | O43405 | |
| QLQIQFQGGFSSRRG | 61 | Q86WQ0 | |
| QGRKKGGSSFRDNFD | 26 | Q9GZY0 | |
| GRLQEFGQFRGFNKS | 171 | Q4VX76 | |
| FGQFRGFNKSVENLF | 176 | Q4VX76 | |
| NNPFAKGFRDTGNGR | 296 | O15119 | |
| FRNGLSNVLFFGLRG | 181 | Q9H1U9 | |
| GRFKGLNGRYFQQQE | 481 | O14594 | |
| VFQKRFNGSVSFFRG | 81 | P55083 | |
| GAGGKGNRFFLANNN | 186 | Q9H4K7 | |
| FRNGLSNVLFFGLRG | 181 | Q3SY17 | |
| GKQCFFNGVFLGNKR | 161 | Q496A3 | |
| GGARFRLLFDRFGQQ | 616 | Q7L0X0 | |
| KGNFPGRFSGRQFSN | 76 | A0A578 | |
| FSREAFFGGNGKINL | 541 | Q8IWR0 | |
| QIFSNDGQFKSRFGI | 511 | Q9C040 |